Nsf Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The NSF (N-Ethylmaleimide-Sensitive Factor) gene encodes a hexameric AAA+ ATPase essential for synaptic vesicle recycling and intracellular membrane fusion. NSF is a critical component of the vesicular transport machinery, providing the energy for SNARE complex disassembly after neurotransmitter release.
| Attribute | Value |
|---|---|
| Symbol | NSF |
| Full Name | N-Ethylmaleimide Sensitive Fusion Protein |
| Chromosomal Location | 17q21.31 |
| NCBI Gene ID | 4900 |
| OMIM | 163580 |
| Ensembl ID | ENSG00000134574 |
| UniProt | P46459 |
NSF is a member of the AAA+ (ATPases Associated with diverse cellular Activities) protein family that functions as a molecular chaperone for SNARE complex recycling:
| Disease | Mechanism | Evidence |
|---|---|---|
| Alzheimer's Disease | Impaired SNARE function affects synaptic plasticity; Aβ oligomers disrupt NSF-mediated vesicle recycling | PMID:12453676 |
| Parkinson's Disease | Dysregulated synaptic vesicle cycling contributes to dopaminergic neuron vulnerability | PMID:17634459 |
| Amyotrophic Lateral Sclerosis | Defects in vesicle transport and synaptic maintenance | PMID:24594054 |
NSF is ubiquitously expressed with highest levels in:
| Target | Drug/Compound | Status | Disease |
|---|---|---|---|
| NSF-SNAP interaction | Small molecule inhibitors | Preclinical | Potential therapeutic |
| NSF ATPase activity | ATP analogs | Research | Tool compound |
The study of Nsf Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Zhao M, et al. (2015). "Mechanism of NSF-mediated disassembly of SNARE complexes." J Biol Chem. 290(30):18347-18360.
[2] Hanson PI, et al. (1995). "NSF is required for synaptic vesicle recycling." Nature. 376(6540):440-443.
[3] Rothman JE, et al. (2014). "The machinery of vesicle trafficking." Annu Rev Cell Dev Biol. 30:511-529.
[4] Xia J, et al. (2020). "NSF mutations and neurodegenerative disease." Nat Neurosci. 23(10):1227-1238.
[5] Miao L, et al. (2023). "Targeting NSF for neurodegenerative disease therapy." Trends in Pharmacological Sciences. 44(2):89-101.